Master of Science in Pharmaceutical Sciences (MSc)
Our research-intensive MSc program offers students the opportunity to conduct outstanding research projects and receive training in a broad range of fields within the pharmaceutical sciences. We provide you with exceptional mentors and supervisors, a rigorous learning environment, and access to state-of-the-art equipment and facilities to conduct your research.
We accept students from a wide range of backgrounds. Students come to us with degrees in pharmaceutical sciences, medicine, biotechnology, the basic and biomedical sciences (e.g., chemistry, biology, biochemistry, microbiology, genetics, pharmacology), engineering (e.g., biomedical, chemical), economics and epidemiology.
What makes the program unique?
As the #1 Pharmaceutical Sciences school in Canada, our faculty and graduate students work at the exciting and ever-expanding edges of the field of pharmacy and pharmaceutical sciences. They're conducting precedent-setting research with real and tangible impact in areas such as discovering and developing new drugs, improving the quality of patient care and treatment outcomes, and developing the practice of pharmacy. The work we do makes a difference in people's lives.
Our graduate degree programs offer you enormous potential in terms of fulfilling career opportunities in industry, government and academia, as well as in other health professions.
Meet a UBC representative
Q&A with UBC Graduate Student Ambassadorswebinar
Date: Monday, 25 June 2018
Time: 16:00 to 17:00
Join our Graduate Student Ambassadors Samuel Adenyanju (MSc Forestry, Nigeria), Federico Andrade (PhD Public Health, Colombia), Maria Angélica Guerrero (MA Educational Studies, Colombia), Xining (Linda) Yang (PhD Pathology and Laboratory Medicine, China) and Dorine Akwiri (Master of Public Policy and Global Affairs, Kenya) who will be available to answer questions about their experiences at UBC, including topics such as accommodation, moving to a new city/province/country and settling in, making friends, being an international student, and more. This session is open to participants interested in different programs across all faculties at UBC. Please note that we will not be able to provide answers to questions regarding application or admissions policies or any that involve specific personal information.
Pioneering research for the first drug-eluting coronary stent was accomplished by our Faculty
The Neglected Global Diseases Initiative was developed in our Faculty. (http://ngdi.ubc.ca)
Collaboration for Outcomes Research and Evaluation was developed in the Faculty of Pharmaceutical Sciences (www.core.ubc.ca)
We are developing focused Graduate Training Programs that will allow MSc and PhD students to tailor their research and educational environments to suit their needs.
Our focused research themes are in: Health Outcomes, Molecular & Systems Pharmacology, Nanomedicine, Genomics and individualized therapy, Epidemiology, and Pharmacy Education. Detailed information can be found at: https://pharmsci.ubc.ca/research/research-themes
We moved into the new Pharmacy building in 2012 which houses modern, modular labs designed specifically for the type of research intended for the space. Our classroom facilities has been fitted with the necessary technology to facilitate new modes of learning.
The Faculty houses a modern mass spectrometer facility of pharmacokinetic and drug metabolism studies and a Sequenom Mass-ARRAY system for genotyping and DNA methylation studies.
TOEFL (ibT) Overall Score Requirement
IELTS Overall Score Requirement
Supervisor commitment required prior to application?
All (domestic and international) students accepted into our MSc program can expect to be paid approximately $21,000 per year, provided they maintain their eligibility as a UBC graduate student. This comprises what we call a "guaranteed stipend" of $19,000, plus Graduate Support Initiative funding (provided to our MSc and PhD students who do not hold external funding), which is currently approximately $2,000 per year for the first two years of the Pharmaceutical Sciences MSc program. This will be paid on a semi-monthly basis in the form of a Graduate Teaching Assistantship and/or a Graduate Research Assistantship. Please be aware that due to the high cost of living, the guaranteed stipend most likely will not be enough, therefore, we strongly suggest students also plan to have their own personal funding in addition to the stipend.
Applicants who are interested in the production, preparation, and application of nuclear isotopes for science and medicine may consider the IsoSiM program that provides additional funding and professional development opportunities. Applicants who are interested in catalysis research with a focus on programs addressing waste generation, environmental compatibility, energy efficiency, and alternative energy sources may consider the SusSyn program.
Tuition / Program Costs
|Fees||Canadian Citizen / Permanent Resident / Refugee / Diplomat||International|
|Installments per year||3||3|
|Tuition per installment||$1,632.61||$2,868.22|
|Tuition per year||$4,897.83||$8,604.66|
|Int. Tuition Award (ITA) per year (if eligible)||$3,200.00 (-)|
|Other Fees and Costs|
|Student Fees (yearly)||$923.38 (approx.)|
|Costs of living (yearly)||starting at $16,884.10 (check cost calculator)|
All fees for the year are subject to adjustment and UBC reserves the right to change any fees without notice at any time, including tuition and student fees. In case of a discrepancy between this webpage and the UBC Calendar, the UBC Calendar entry will be held to be correct.
Completion Rates & Times
This list shows faculty members with full supervisory privileges who are affiliated with this program. It is not a comprehensive list of all potential supervisors as faculty from other programs or faculty members without full supervisory privileges can request approvals to supervise graduate students in this program.
Bandiera, Stelvio (drug metabolism; drug toxicity; drug interactions; steroids; toxicology including environmental pollutants such as pesticides, PCBs, TCDD and dioxins; effects on animals, biochemical toxicology, , Hepatic drug metabolism and environmental toxicology, chemical and biochemical aspects of drug metabolism, medicinal chemistry, structure-activity relationship)
Burt, Helen Mary (Nanotechnology, non-sized drug carriers, nanoparticulte drug delivery)
Cairns, Brian (Neuropharmacology, Oro-Facial Pain, Pain, Electrophysiology, pain mechanisms, headache, temporomandibular disorders, sex-related differences, peripheral analgesics)
Chang, Thomas (Drug Metabolism, Pharmacology, Nuclear Receptor, Drug-Metabolizing Enzymes, Cytochrome P450, Gene Expression, Gene Regulation)
Collier, Abby (Drugs in children, Drugs in pregnancy, Developmental pharmacology, Drug metabolism, Pharmacokinetics, Drug metabolism and pharmacokinetics, primarily of the phase II (conjugation) enzymes, focused on pregnancy and pediatrics)
Conklin, Annalijn (Chronic Diseases in Elderly, Gender Epidemiology, Health Policies, Professional Practices, Obesity, Social Determinants of Dietary and Metabolic Disorders, Community Health / Public Health, healthy ageing, obesity prevention, diabetes management and evaluation, healthcare quality improvement, implementation science, gender and health equity, nutrition-related policy and outcomes)
Coughtrie, Michael (Drug metabolizing enzymes)
De Vera, Mary (examining how eHealth technologies can support new and existing models of care to improve care delivery and patient outcomes; exploring patients' perspectives and experiences with medication taking and adherence; and evaluating the use and impacts of medications among pregnant women, particularly with inflammatory conditions.)
Frankel, Adam (family of human enzymes called protein arginine N-methyltransferases (PRMTs), which transfer methyl groups from S-adenosyl-L-methionine to arginine residues within proteins; contribution of PRMT activities to human diseases such as hormone-dependent cancers, inflammation, and cardiovascular disease)
Giaever, Guri (Model organisms, human therapeutics, high-throughput cell biology, drug synergy, technologies for understanding relationship between chromatic structure and transcriptional regulation)
Grierson, David (Chemistry, disease, biochemistry)
Hafeli, Urs (Pharmacokinetics, Imaging, Radiotherapy, Immunotherapy, Development of Drug Delivery Systems, Radiopharmaceuticals, Radioimmunotherapy, Magnetic Targeting, Targeted Drug Delivery, Novel polymers, Nanoparticles, Microspheres, Microneedles, Bioconjugates)
Harrison, Mark (measurement and valuation of health, health technology and policy assessment, and preferences for healthcare interventions; evaluation/re-evaluation of the type of health care that is provided, the point in the treatment pathway, and the way in which it is delivered)
Jarvis-Selinger, Sandra Ann (Education, human learning, development, and instruction, education innovation, konwledge translation, teaching excellence, curriculum design, technology)
Kumar, Ujendra (Somatostatin hormone, molecular pharmacology, Somatostatin, , Hormones, somatostatin, locomotor and cognitive function, neurodegenerative diseases, drugs)
Lalji, Fawziah (Pharmacoepidemiology, Infectious Diseases, Vaccination, Antibiotics and Resistance, Tuberculosis)
Li, Shyh-dar (drug delivery, pharmaceutics, nanomedicine, biopharmaceutics)
Loewen, Peter (Arrhythmia, Cardiovascular Diseases, Heart Failure, Stroke, Thrombosis and Embolism, Health Care Technologies, Professional Practices, Pharmacoepidemiology, Hematology, Decision Making, atrial fibrillation, stroke prevention therapy, pharmacy practice, knowledge translation of evidence to patient care, patient education, shared decision-making, clinical prediction rules, prediction of stroke and bleeding in atrial fibrillation patients, patient decision aids, adherence to medication, patient complexiometry, healthcare communication technologies, use of mobile technology for clinical decision-making, hospital pharmacy practice, quality of care, quality drug therapy)
Lynd, Larry (health economics, orphan drugs, pharmaceutical policy, respiratory medicine, epidemiology, pharmacoepidemiology, rare diseases )
MacLeod, Kathleen (Cardiovascular complications, diabetes )
McCormack, James (Knowledge translation and evidence-based practice)
Nislow, Corey (genomics and develops biotechnology tools to address both fundamental and applied biological questions; Parallel genome-wide chemical genomic screens; High throughput cell-based screens; Next Generation Sequencing)
Rodrigues, Brian (Diabetes, Cardiomyopathy, Cardiovascular metabolism, Diabetes, Endothelial cell - cardiomyocyte crosstalk)
Ross, Colin (Biomedical Technologies, Gene Therapy, Drug Metabolism, Transgenic Model, Pharmacogenomics, Gene-based therapeutics, Precision medicine)
Sadatsafavi, Mohsen (respiratory medicine with the aim of improving patient outcomes and the efficiency of health care delivery through evidence-informed decision making at all levels of care)